Black Diamond Therapeutics, Inc.·4

Feb 17, 4:17 PM ET

Jones Erika 4

4 · Black Diamond Therapeutics, Inc. · Filed Feb 17, 2022

Insider Transaction Report

Form 4
Period: 2022-02-15
Jones Erika
SEE REMARKS
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-02-15+20,30020,300 total
    Exercise: $3.79Exp: 2032-02-14Common Stock (20,300 underlying)
  • Award

    Common Stock

    2022-02-15+5,0755,075 total
Footnotes (2)
  • [F1]Represents a grant of Restricted Stock Units ("RSUs") under the Black Diamond Therapeutics, Inc. 2020 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs shall vest as follows: 35% on the 9 month anniversary of February 15, 2022 (the "Vesting Commencement Date"), 35% on the 18 month anniversary of the Vesting Commencement Date, and the remaining 30% on the 27 month anniversary of the Vesting Commencement Date.
  • [F2]25% of the shares subject to this option shall vest and become exercisable on February 15, 2023, with the remainder vesting in 36 equal monthly installments thereafter.

Documents

1 file
  • 4
    form4-02172022_010228.xmlPrimary